These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Recent developments in alcoholism:molecular biology and behavior.
    Author: Noble EP, Paredes A.
    Journal: Recent Dev Alcohol; 1993; 11():345-62. PubMed ID: 7901878.
    Abstract:
    Following our initial observation that the A1 allele of the D2 dopamine receptor (DRD2) gene was associated with alcoholism, a number of studies, both in the United States and abroad, have attempted to replicate and extend this finding in different Caucasian populations. In nine independent studies containing a total of 491 heterogeneous alcoholics (less severe and severe) and 495 heterogeneous controls (assessed and unassessed for alcoholism), the prevalence of the A1 allele was 43.0% in the former group compared with 25.7% in the latter groups (odds ratio = 2.18, p < 10(-6). The prevalence of the A1 allele increased to 56.3% in a more homogeneous sample of 158 severe alcoholics (odds ratio = 3.32, p < 10(-8)). Moreover, the B1 allele of the DRD2 gene was also found to be significantly associated with severe alcoholism. Additional data are accruing which also implicate the DRD2 A1 and B1 alleles in substance use disorders other than alcoholism. If further studies continue to support the results currently available, they would indicate that the DRD2 gene is the most prominent single gene determinant of susceptibility to severe substance abuse. However, the larger role still appears to be played by a combination of environmental factors and as yet unidentified genes.
    [Abstract] [Full Text] [Related] [New Search]